Immunomodulation property of hexane fraction of leaves of Cinnamomum tamala Linn. in rats.
The leaves of Cinnamomum tamala Linn. (CT) (Lauraceae) clinically used in Ayurveda as antidiabetic and diuretic, but no reports are available towards immunomodulating property. Its hexane fraction (CTH) was orally given to rats for 10 days and delayed type of hypersensitivity (DTH), antibody production against sheep red blood cells (SRBCs), mitotic index in bone marrow cells and concanavalin A (Con A) mediated proliferation of lymphocytes were assessed. Further on 30 days treatment, change in body weight (BW), spleen weight, thymus weight, bone marrow cellularity and hematological changes were observed. It inhibited significantly the DTH response (IC(50) 1475 +/- 57.19 mg kg(-1) BW), antibody production, suppressed mitotic index in bone marrow cells along with the suppression of lymphocyte proliferation against Con A (IC(50) 63.33 +/- 1.95 microg mL(-1)). In all experiments, cyclophasphamide and dexamethasone had been used as reference drug for in vivo and in vitro studies, respectively. On 30 days treatment, the CTH (800 mg kg(-1) BW and above) significantly suppressed growth rate, increase of spleen and thymus weight and low bone marrow cellularity. In hematological examination, it inhibited total white blood cell and lymphocytes count and increased per cent of polymorphs. Thus, it could be suggested that the fraction possesses immunosuppressive property at doses, higher than 800 mg kg(-1) BW in rats.
Chaurasia
Jitendra K
JK
Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanari, India.
Mishra
Anshulika
A
Tripathi
Yamini B
YB
D000284:Administration, Oral; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D027424:Cinnamomum / Q000737:chemistry*; D004195:Disease Models, Animal; D006586:Hexanes / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D009929:Organ Size / Q000187:drug effects; D010936:Plant Extracts / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D011897:Random Allocation; D051381:Rats
D006586:Hexanes; D007155:Immunologic Factors; D010936:Plant Extracts; C026385:n-hexane